MedTrace Logo

Determination of ALDH1b1 and ALDH2 Polymorphisms Frequency in the Brazilian Population

NCT04270201 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-05-19

No results posted yet for this study

Summary

A case-control study with oral squamous cell carcinoma (OSCC) patients from Instituto do Câncer do Estado de São Paulo (ICESP) and healthy volunteers. In this study, it will be collected saliva samples from both groups that will be submitted to sequencing analysis to evaluate the frequency of ALDH1b1 and ALDH2 polymorphisms in the Brazilian population. Also, correlate OSCC risk to alcohol consumption or smoke, by applied questionnaires.

Conditions

  • Oral Squamous Cell Carcinoma (OSCC)

Interventions

OTHER

Saliva collection

Saliva collection

Sponsors & Collaborators

  • Instituto de Ciências Biomédicas da Universidade de São Paulo

    collaborator UNKNOWN

  • Instituto do Cancer do Estado de São Paulo

    lead OTHER

Principal Investigators

  • Gilberto de Castro Junior, MD, PhD · Instituto do Câncer do Estado de São Paulo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-02
Primary Completion
2022-12-01
Completion
2023-12-01

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04270201 on ClinicalTrials.gov